コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and intestinal humoral responses and select intestinal microbiota.
2 this phenotype requires the presence of the intestinal microbiota.
3 cifically reduce the virome component of the intestinal microbiota.
4 n influencing the community structure of the intestinal microbiota.
5 mucosal surfaces and coats a fraction of the intestinal microbiota.
6 ic immune responses can be influenced by the intestinal microbiota.
7 g enterococci or between enterococci and the intestinal microbiota.
8 in has more impact than ciprofloxacin on the intestinal microbiota.
9 s to life in the cold are facilitated by the intestinal microbiota.
10 One possible modulator could be the intestinal microbiota.
11 acted from mouse fecal samples to assess the intestinal microbiota.
12 gnificantly affecting the structure of their intestinal microbiota.
13 odels, particularly in the presence of other intestinal microbiota.
14 tative (overgrowth) dysbiotic changes in the intestinal microbiota.
15 colonized with 2 different types of complex intestinal microbiota.
16 modeling and current efforts in modeling the intestinal microbiota.
17 without affecting the colitogenicity of the intestinal microbiota.
18 y based on modulating the composition of the intestinal microbiota.
19 ning and accompanying diversification of the intestinal microbiota.
20 diet markedly affects the composition of the intestinal microbiota.
21 Antibiotic therapy disrupts the human intestinal microbiota.
22 D88 pathways, and involves modulation of the intestinal microbiota.
23 rrelates strongly with the complexity of the intestinal microbiota.
24 be triggered through the intervention of the intestinal microbiota.
25 rlying role for aberrant immune responses to intestinal microbiota.
26 epithelium and thus promote tolerance to the intestinal microbiota.
27 stem has inappropriate interactions with the intestinal microbiota.
28 implicate an aberrant immune response to the intestinal microbiota.
29 e cell numbers depend on the presence of the intestinal microbiota.
30 elationship to other components of the human intestinal microbiota.
31 viously considered to be associated with the intestinal microbiota.
32 l alpha-diversity and differentially altered intestinal microbiota.
33 ction of endogenous ligands or modulation of intestinal microbiota.
34 ed by increased effector T cells reactive to intestinal microbiota.
35 dylcholine is dependent on metabolism by the intestinal microbiota.
36 ve treatments that significantly disrupt the intestinal microbiota.
37 ated intestinal fibrosis without influencing intestinal microbiota.
38 pplicability of new strategies targeting the intestinal microbiota.
39 tion of the diversity and composition of the intestinal microbiota.
40 ted responses of human CD4(+) T cells to the intestinal microbiota.
41 Here, we investigated the involvement of intestinal microbiota.
42 ave been shown to be vital components of the intestinal microbiota.
43 ted with host antigens, including autologous intestinal microbiota.
44 cooperative phenotypes within the mammalian intestinal microbiota.
45 ents in the establishment/maintenance of the intestinal microbiota.
46 tion of proteomics for functional studies of intestinal microbiota.
47 uman health benefits via their impact on the intestinal microbiota.
48 the gut, where their presence depends on the intestinal microbiota.
49 tibility to vancomycin-induced alteration of intestinal microbiota.
50 enefits of breastfeeding are conveyed by the intestinal microbiota.
51 We showed considerable shifts within the intestinal microbiota 14-24 d postweaning in mice that w
53 a2g1b by epithelial cells was dependent upon intestinal microbiota, adaptive immunity, and common-gam
54 he complex interactions between diet and the intestinal microbiota affect development of mucosal infl
56 We investigated how the composition of the intestinal microbiota affects its endotoxicity and devel
57 recede arthritis, and that modulation of the intestinal microbiota after the onset of arthritis may o
59 at additional environmental factors, such as intestinal microbiota alterations, are involved in its p
60 gs identify previously unknown links between intestinal microbiota alterations, circulating amino aci
61 al peptides, which leads to dysbiosis of the intestinal microbiota, alters the mucosal barrier, and p
62 fh cells demonstrated that they required the intestinal microbiota and a diverse repertoire of CD4(+)
63 e of the structure and function of the human intestinal microbiota and C. difficile pathogenesis has
65 te that environmental factors, including the intestinal microbiota and changes in diet, can alter nor
66 e association between the composition of the intestinal microbiota and clinical features of irritable
67 e association between the composition of the intestinal microbiota and clinical features of irritable
68 pacts of metronidazole and vancomycin on the intestinal microbiota and colonization resistance are un
69 significant and long-lasting effects on the intestinal microbiota and consequently reduce colonizati
70 ection in that its expression suppressed the intestinal microbiota and enhanced the colonization of a
71 re fermentation end products produced by the intestinal microbiota and have anti-inflammatory and his
75 icant expansion of Proteobacteria within the intestinal microbiota and increased proinflammatory LP c
76 Lyn plays a critical role in regulating the intestinal microbiota and inflammatory responses as well
80 iotics play important roles in the growth of intestinal microbiota and may impact on the intestinal h
81 our understanding of connections between the intestinal microbiota and metabolites at a whole-systems
82 information on the functional activities of intestinal microbiota and on host-microbe interactions a
83 of orally infected mice that alters the host intestinal microbiota and promotes intestinal colonizati
84 he presence of pyrrolobenzodiazepines in the intestinal microbiota and provide a mechanism for coliti
85 aled the ability of P. copri to dominate the intestinal microbiota and resulted in an increased sensi
86 , we discuss the novel and emerging field of intestinal microbiota and roles of gut permeability and
87 nd a prebiotic (OI) to selectively alter the intestinal microbiota and significantly reduce body weig
88 that IAP preserves the normal homeostasis of intestinal microbiota and that oral supplementation with
89 during early larval development requires the intestinal microbiota and that specific bacterial member
90 ew of the interactions occurring between the intestinal microbiota and the immune system, and we will
93 ropyl methylcellulose (HPMC) could alter the intestinal microbiota and whether such changes correlate
94 tion alters the composition of the bacterial intestinal microbiota and, conversely, that the presence
97 n humans, TMA is produced exclusively by the intestinal microbiota, and its metabolite, trimethylamin
98 erscore the importance of in vivo studies of intestinal microbiota, and the approach presented in thi
100 ge, and the serum IgG response to a panel of intestinal microbiota antigens was assessed by using a n
102 ta-glucuronidases expressed by the symbiotic intestinal microbiota appear to play important roles in
103 lationship between the host and its resident intestinal microbiota, appropriate mucosal T cell respon
104 ifferent bacterial communities, finding that intestinal microbiota are a major contributor to disease
105 une, and endothelial cells together with the intestinal microbiota are involved in IBD pathogenesis.
107 ested the hypothesis that alterations in the intestinal microbiota are linked with the progression of
108 ed on geographic and cultural differences in intestinal microbiota are necessary to define applicabil
109 responses directed against antigens from the intestinal microbiota are observed in certain diseases,
112 summary a 3-day juice-based diet altered the intestinal microbiota associated with weight loss, incre
114 t on the expansion of a common member of the intestinal microbiota Bacteroides vulgatus, which also m
116 t genetics as well as the composition of the intestinal microbiota, but the effects of stressor expos
119 data also demonstrate that disruption of the intestinal microbiota by antibiotic treatment prevents p
120 flore), in 20 of the 64 NICUs, analyzed the intestinal microbiota by culture and 16S ribosomal RNA g
122 in which the host may maintain tolerance to intestinal microbiota by rendering lamina propria macrop
124 kely secondary to innate immune responses to intestinal microbiota by the premature infant's intestin
128 undance and metabolic characteristics of the intestinal microbiota change substantially in those who
129 bjects with moderate genetic susceptibility, intestinal microbiota changes may be a factor that incre
130 to a challenge with C. rodentium alters the intestinal microbiota community structure, including a r
131 which recognizes flagellin, have an altered intestinal microbiota composition compared with wild-typ
132 se phenotypes are not clear; modification of intestinal microbiota composition has been reported to r
135 sed the relation between feeding strategies, intestinal microbiota composition, and the development o
137 e gastrointestinal tract is regulated by the intestinal microbiota composition, particularly the pres
138 on was associated with significantly altered intestinal microbiota composition, which was linked to a
140 abundant Gram-negative bacteria of the human intestinal microbiota comprising more than half of the b
142 ize that generation of this biopterin by the intestinal microbiota contributes to its tissue increase
143 ge-dependent and societal differences in the intestinal microbiota could result from differences in d
144 ironmental factors with a profound impact on intestinal microbiota, data on antibiotic use as a risk
148 nt metronidazole, are associated with marked intestinal microbiota destruction and greater risk of co
154 host mild but significant differences in the intestinal microbiotas during a critical early window of
157 l cancer cell colonization or proliferation, intestinal microbiota effects, or tumoricidal activity b
159 ronment, which suggests major changes in the intestinal microbiota following movement to saltwater.
162 standing how the mammalian immune system and intestinal microbiota functionally interact have yielded
171 ions in the composition and functions of the intestinal microbiota have been implicated in multiple d
173 rganisms as well as members of the commensal intestinal microbiota have been shown to be able to brea
174 urinary 3-indoxyl sulfate is a biomarker of intestinal microbiota health and predicts reduced intest
176 to lead to durable alterations to the murine intestinal microbiota, ileal gene expression, specific i
179 cular, experimental manipulations that alter intestinal microbiota impact exploratory and communicati
181 jective was to identify early differences in intestinal microbiota in a cohort of breastfeeding infan
183 ids in fecal samples, and composition of the intestinal microbiota in children with overweight or obe
184 licated in changes in the composition of the intestinal microbiota in Crohn's disease, but its role o
188 ablished through characterization of altered intestinal microbiota in IBS patients and reported impro
189 state of knowledge regarding the role of the intestinal microbiota in immunologic development, highli
190 tive cancer, supporting a potential role for intestinal microbiota in mediating the association betwe
191 amentous bacteria (sfb), but the role of the intestinal microbiota in pulmonary host defense is not w
193 supporting the important role for early-life intestinal microbiota in the development of childhood as
194 have produced evidence for a causal role of intestinal microbiota in the etiology of obesity and ins
200 ed to spontaneous colitis in the presence of intestinal microbiota, indicating that microbial factors
201 It was our hypothesis that changes in the intestinal microbiota induced by a juice-based diet play
204 hogens and changes in the composition of the intestinal microbiota initiate this process, which leads
205 The endotoxicity of LPS produced by the intestinal microbiota is a determinant of whether mice d
211 tiple antibiotics, tend to colonize when the intestinal microbiota is dysbiotic, and elicit a severe
214 Moreover, it is now well admitted that the intestinal microbiota is involved in shaping and maturat
218 eating organized ecological units within the intestinal microbiota, knowledge of which can be applied
219 s aureus and Staphylococcus epidermidis) and intestinal microbiota (Lactobacillus reuteri, Enterococc
220 odulatory activity or through effects on the intestinal microbiota leading to reduced microbial trans
221 ouse colons is accompanied by a reprogrammed intestinal microbiota, leading to a transmissible reduce
222 we present a pipeline for the assessment of intestinal microbiota localization within immunofluoresc
223 , chronic infections and disturbances in the intestinal microbiota; low-grade mucosal inflammation, i
224 Increasing our understanding of how the intestinal microbiota manage C difficile could lead to b
226 These observations suggest that altered intestinal microbiota may be associated with disease sus
228 An emerging body of work suggests that the intestinal microbiota may help to explain some of these
230 A recent study suggested that early-life intestinal microbiota may play an important role in the
231 ce, but not in LFD mice, indicating that the intestinal microbiota may play differing roles during th
236 nship between inflammasome signaling and the intestinal microbiota might provide insight into the com
238 sulitis, an effect that was dependent on the intestinal microbiota; moreover, they developed autoimmu
239 ociations, along with interactions among the intestinal microbiota, mucus layer, bile acids, and muco
240 hing a critical mechanistic link between the intestinal microbiota, namely segmented filamentous bact
241 hough both Toll and IMD effectors controlled intestinal microbiota, neither affected Trypanosoma cruz
243 east 50-60% of the bacterial genera from the intestinal microbiota of a healthy individual produce re
251 Interestingly, Bacteroidetes dominated the intestinal microbiota of streptomycin-treated animals, w
253 e systemic impact of both these Treg and the intestinal microbiota on the human immune homeostasis.
256 ause accumulating evidence has revealed that intestinal microbiota play an important role in human he
261 s have described how helminths may alter the intestinal microbiota, potentially representing a mechan
262 o assess the adaptive immune response to the intestinal microbiota present in 143 healthy adults and
264 ates the composition and localization of the intestinal microbiota, preventing diseases associated wi
265 BS and healthy individuals, we identified an intestinal microbiota profile that is associated with th
266 verse microbial populations constituting the intestinal microbiota promote immune development and dif
269 odeficient or chemotherapy-treated mice, the intestinal microbiota provides nonredundant defense agai
270 ngs provide mechanistic insight into how the intestinal microbiota regulates body composition and est
271 racteristic shifts in the composition of the intestinal microbiota, reinforcing the view that IBD res
272 Further, 16S rRNA sequence analysis of the intestinal microbiota revealed marked changes in the com
273 Inhibition of FPRL1, but not suppression of intestinal microbiota, reversed these protective effects
274 acterial pathogenicity in the context of the intestinal microbiota should unveil new approaches for d
275 of 16S rRNA transcripts from the indigenous intestinal microbiota showed that WD resulted in signifi
280 which lack all NKT cells, harbor an altered intestinal microbiota that is associated with exacerbate
281 icobacter hepaticus is a member of the mouse intestinal microbiota that is tolerated by the host.
283 demonstrate that reintroduction of a diverse intestinal microbiota to densely VRE-colonized mice elim
284 potential therapeutic power of manipulating intestinal microbiota to ensure host metabolic health an
285 in vitro studies of the contribution of the intestinal microbiota to infectious disease are discusse
288 lationships among diet, GI motility, and the intestinal microbiota using mice that are germ-free (GF)
291 rus replication was reduced in vivo when the intestinal microbiota was depleted by means of oral anti
294 system also acts indirectly by "farming" the intestinal microbiota, which then influences brain devel
296 to characterize taxa-specific coating of the intestinal microbiota with immunoglobulin A (IgA-SEQ) an
298 AIMS: It might be possible to manipulate the intestinal microbiota with prebiotics or other agents to
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。